Author:
Ollier Edouard,Hodin Sophie,Lanoiselée Julien,Escal Jean,Accassat Sandrine,De Magalhaes Elodie,Basset Thierry,Bertoletti Laurent,Mismetti Patrick,Delavenne Xavier
Funder
Centre Hospitalier Universitaire de Saint Etienne
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–62.
2. Juurlink DN. Activated charcoal for acute overdose: a reappraisal. Br J Clin Pharmacol. 2016;81:482–7.
3. Cooper JM, Duffull SB, Saiao AS, Isbister GK. The pharmacokinetics of sertraline in overdose and the effect of activated charcoal. Br J Clin Pharmacol. 2015;79:307–15.
4. European Medicines Agency. CHMP: Xarelto, INN-rivaroxaban. 2008. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf . Accessed 15 Jun 2016.
5. Weinz C, Schwarz T, Kubitza D, et al. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metab Dispos. 2009;37:1056–64.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献